Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
02/2011
02/03/2011US20110027356 Combination of Oral Medicaments Bonded by a Wrapping
02/03/2011US20110027349 Polypeptide vaccine and vaccination strategy against mycobacterium
02/03/2011US20110027341 Device for in situ production and topical administration of allicin
02/03/2011US20110027327 Cosmetic or pharmaceutical composition for topical application
02/03/2011US20110027321 Chlamydia Vaccine Comprising HtrA Polypeptides
02/03/2011US20110027319 Methods of eliciting or boosting a cellular immune response
02/03/2011US20110027318 Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis
02/03/2011US20110027317 Production of poliovirus at high titers for vaccine production
02/03/2011US20110027316 Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same
02/03/2011US20110027315 Protein cages and their uses
02/03/2011US20110027313 Viral recombineering and uses thereof
02/03/2011US20110027312 CHIMERIC PORCINE CIRCOVIRUS PCV2Gen-1Rep AND USES THEREOF
02/03/2011US20110027309 Compositions and methods of enhancing immune responses
02/03/2011US20110027308 Compositions and methods for preventing influenza infection in canines, felines and equines
02/03/2011US20110027306 TC-83-Derived Alphavirus Vectors, Particles and Methods
02/03/2011US20110027304 Yersinia pestis antigens, vaccine compositions and related methods
02/03/2011US20110027300 Identification of a novel cysteine-rich cell penetrating peptide
02/03/2011US20110027295 Adenosine Receptor Agonists and Antagonists to Modulate T Cell Responses
02/03/2011US20110027294 Anti-Respiratory Syncytial Virus Antibodies, Antigens and Uses Thereof
02/03/2011US20110027293 Methods and compositions for the inhibition of viral infection by targeting intracellular trafficking
02/03/2011US20110027285 Methods and agents modulating upa/upar activity
02/03/2011US20110027282 Interferon antagonists, antibodies thereto and associated methods of use
02/03/2011US20110027281 Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor
02/03/2011US20110027280 Methods For Inducing Autolysis In Infectious Bacteria
02/03/2011US20110027272 Stabilized liquid anti-rsv antibody formulations
02/03/2011US20110027271 Antibody composition exhibiting cellular cytotoxicty due to glycosylation
02/03/2011US20110027270 Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
02/03/2011US20110027265 Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions
02/03/2011US20110027259 Component of bromelain
02/03/2011US20110027255 Composition and Method for Treating Papilloma Virus and Equine Sarcoids
02/03/2011US20110027249 Fusion of Peptidoglycan Hydrolase Enzymes to a Protein Transduction Domain Allows Eradication of both Extracellular and Intracellular Gram Positive Pathogens
02/03/2011US20110027243 Composition based on probiotic bacteria in association with a prebiotic and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of intestinal functionality
02/03/2011US20110027240 Secretable hiv entry inhibitory peptides for therapy of hiv infection
02/03/2011US20110027231 Method for the random diversification of a genetic sequence while preserving the identity of some inner segments of said genetic sequence
02/03/2011US20110027229 Continuous subcutaneous administration of interferon-alpha to hepatitis c infected patients
02/03/2011US20110027227 Antiviral drugs for treatment of arenavirus infection
02/03/2011US20110027224 Use of a cytokine from the interleukin-6 family in the preparation of a composition for combined administration with interferon-alpha
02/03/2011US20110027200 Methods to stabilize and prevent breakdown of sunscreen and other topical and oral preparations and compositions produced thereby
02/03/2011US20110027194 Hypochlorite denture compositions and methods of use
02/03/2011US20110027183 Hydrophobic Modified Pres-Derived Peptides of Hepatitis B Virus (HBV) and Their Use as Vehicles for the Specific Delivery of Compounds to the Liver
02/03/2011CA2769645A1 Polymer particles and uses thereof
02/03/2011CA2769359A1 Nitroimidazooxazines and their uses in anti-tubercular therapy
02/03/2011CA2769263A1 Nitroimidazooxazine and nitroimidazooxazole analogues and their uses
02/03/2011CA2769161A1 Phthalocyanine derivative consisting of a mixture of 4 isomers
02/03/2011CA2768997A1 High yield yellow fever virus strain with increased propagation in cells
02/03/2011CA2768887A1 Orf7 deficient varicella virus, vaccine comprising the virus and use thereof
02/03/2011CA2768290A1 R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for thepreparation thereof and pharmaceutical composition comprising the same for antimicrobial
02/02/2011EP2280074A2 Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof
02/02/2011EP2280072A2 Group B streptococcus antigens
02/02/2011EP2280071A2 Haemophilus influenzae antigens and corresponding DNA fragments
02/02/2011EP2280070A1 Methods and compositions for RNAi mediated inhibition of gene expression in mammals
02/02/2011EP2280066A2 Recombinant Clostridium neurotoxin fragments
02/02/2011EP2280012A2 Pyrrolo[2,1-f][1,2,4]triazine derivatives as kinase inhibitors
02/02/2011EP2279755A2 Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF)
02/02/2011EP2279754A2 Remodelling and glycoconjugation of human growth hormone (hGH)
02/02/2011EP2279753A2 Remodeling and glycoconjugation of peptides
02/02/2011EP2279750A1 Aniline derivative having anti-rna viral activity
02/02/2011EP2279748A1 Multivalent vaccine composition
02/02/2011EP2279744A2 ApoE mimetic agents
02/02/2011EP2279743A2 ApoE mimetic agents
02/02/2011EP2279738A1 The use of quaternary pyridinium salts as vasoprotective agents
02/02/2011EP2279737A1 Heterocyclic compounds that are active as beta lactamase inhibitors
02/02/2011EP2279736A1 Microbicidal and antiparasitic compositions comprising quassinoids or quassionid-containing plant extracts
02/02/2011EP2279730A1 Medium chain fatty acids applicable as anti-microbial agents against Enterococcus sp.
02/02/2011EP2279662A2 5,7,4'-trihydroxy-3',5'-dimethoxyflavone as an antibacterial agent
02/02/2011EP2279202A1 Multimeric forms of antimicrobial peptides
02/02/2011EP2279195A1 Medicinal applications of benzoic acid hydrazones synthesized on the basis of steroidal tigogenin
02/02/2011EP2278989A2 Methods of inhibiting and treating biofilms using glycopeptide antibiotics
02/02/2011EP2278977A1 Aromatic heterocyclic fused indolobenzadiazepine hcv ns5b inhibitors
02/02/2011EP2278965A2 Substituted pyrazolamides and the use thereof
02/02/2011EP2278956A1 Antiviral formulation
02/02/2011EP2123173B1 Method for feeding mother pigs with grifola
02/02/2011EP1485358B1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
02/02/2011EP1343520B1 New therapeutic uses of smr1 peptides
02/02/2011EP1039893B1 Pharmaceutical compositions containing an omega-3 fatty acid oil
02/02/2011EP1020179B9 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
02/02/2011CN201727175U Healthcare seat cushion with plants
02/02/2011CN1927388B Medicinal composition containing human interferon
02/02/2011CN1897958B Antiviral preparations obtained from a natural cinnamon extract
02/02/2011CN1767843B Method for preparing antimicrobial agent and antioxidant position from sea-buckthorn seeds
02/02/2011CN101965396A Recombinant vaccinia virus having hepatitis c virus gene
02/02/2011CN101965354A Novel 7-substituted 3-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
02/02/2011CN101965353A Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
02/02/2011CN101962648A Duck source coronavirus ORF1a protein gene and cloning method and application thereof
02/02/2011CN101962625A Salmonella choleraesuis gene deletion mutant without resistant marker and vaccine thereof
02/02/2011CN101962415A Method for preparing low molecular weight brown seaweed fucoidan sulfate
02/02/2011CN101962400A Linear epitope minimum motif peptide of human papilloma virus type 58 L1 protein and application thereof
02/02/2011CN101962370A Novel oxygen heterocyclic compound, salt thereof and preparation method and application of both
02/02/2011CN101961488A Method for preparing serum for resisting Muscovy duck parvovrius
02/02/2011CN101961475A Traditional Chinese medicine for treating liver disease
02/02/2011CN101961463A Chinese medicinal preparation for treating acquired immune deficiency syndrome (AIDS) and preparation method thereof
02/02/2011CN101961449A Traditional Chinese medicine for treating tinea corporis
02/02/2011CN101961445A Method for simultaneously extracting various bioactive components from Chinese yam by using subcritical water as medium
02/02/2011CN101961438A External traditional Chinese medicinal liquor for treating psoriasis
02/02/2011CN101961430A Quality analysis method of compound Ganmaoling tablets
02/02/2011CN101961414A Medicament for preventing and curing grass carp bleeding disease
02/02/2011CN101961404A Chinese medicinal paste for treating dermatosis and preparation method thereof
02/02/2011CN101961396A Medicament for preventing and treating influenza
02/02/2011CN101961391A Traditional Chinese medicine composition for preventing and controlling grass carp disease
02/02/2011CN101961388A Balneation effervescent tablet for preventing heat type common cold